US2020215189A1PendingUtilityA1

Iscom preparation and use thereof

Assignee: Novavax ABPriority: Jul 5, 2002Filed: Mar 19, 2020Published: Jul 9, 2020
Est. expiryJul 5, 2022(expired)· nominal 20-yr term from priority
A61P 37/04A61P 31/16A61P 31/04A61P 31/12A61K 2039/55577A61P 43/00A61K 39/39A61P 31/22A61P 31/14A61P 31/20
59
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The invention relates to a composition comprising a mixture of at least two iscom complexes each complex comprising essentially one saponin fraction from Quillaja saponaria Molina. The complexes may be iscom complexes or iscom matrix complexes. The invention also pertains to the use of such a mixture for the preparation of an immunomodulating pharmaceutical, and adjuvant, formulations for immunization, e.g. for production of monoclonal antibodies, and a vaccine. Kits of parts comprising at least two parts, wherein each part comprises one iscom complex or one iscom matrix complex according to the invention are also embraced.

Claims

exact text as granted — not AI-modified
1 . A composition comprising a mixture of at least two iscom complexes, chosen from iscom and iscom matrix complexes, each complex comprising essentially one saponin fraction from  Quillaja saponaria  Molina.

Join the waitlist — get patent alerts

Track US2020215189A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.